Home > A global picture of injecting drug use, HIV and anti-HCV prevalence among people who inject drugs, and coverage of harm reduction interventions.

Larney, Sarah [NDARC] . (2017) A global picture of injecting drug use, HIV and anti-HCV prevalence among people who inject drugs, and coverage of harm reduction interventions. NDARC, NDRI, NCETA. Drug and Alcohol Research Connections, December 2017

URL: http://connections.edu.au/researchfocus/global-pic...

Understanding how many people inject drugs is critically important for the effective provision of public health and harm reduction services. However, the severe stigma that is often attached to injecting drug use, and illicit nature of this behaviour, means that it is often difficult to have a clear picture of how many people inject drugs in a given nation or region.1 Without this basic population number, it is also difficult to know how many people who inject drugs are living with HIV or hepatitis C virus (HCV), or to know how well HIV and HCV prevention interventions such as needle and syringe programs and opioid substitution therapy are reaching people in need.

We sought to review evidence globally to estimate:
1. The number of people who inject drugs
2. Women and young people as a proportion of people who inject drugs
3. HIV and HCV antibody (anti-HCV) prevalence among people who inject drugs
4. Coverage of needle and syringe programs (NSP) and opioid substitution therapy (OST)

For each of these, we calculated national, regional and global estimates. Estimates were calculated from data presented in peer-reviewed literature and reports from government departments, non-government agencies, and international organisations such as UNAIDS and the Global Fund.


Item Type:Evidence resource
Publication Type:Report
Drug Type:Opioid
Intervention Type:AOD disorder, AOD disorder harm reduction
Source:NDARC
Date:December 2017
Publisher:NDARC, NDRI, NCETA
Volume:December 2017
EndNote:View
Subjects:G Health and disease > Disorder by cause > Communicable disease > HIV infection
G Health and disease > Disorder by cause > Communicable disease > Hepatitis C
J Health care, prevention and rehabilitation > Drugs and alcohol prevention > Drugs and alcohol use harm reduction
J Health care, prevention and rehabilitation > Health-related prevention > Health information and education > Communicable disease control
T Demographic characteristics > Adolescent / youth (teenager / young person)
T Demographic characteristics > Intravenous / injecting drug user

Repository Staff Only: item control page